← Back to Search

Behavioral Intervention

Diabetes Education for Type 1 Diabetes

N/A

Recruiting

Led By Teaniese L Davis, PhD

Research Sponsored by Kaiser Permanente

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Aged 18 - 30 years

Confirmed diagnosis of Type 1 diabetes

Must not have

Subjects with visual impairment or have severe hearing or other physical disabilities that would be a barrier for participating in-group or web sessions

Diabetes complications that would preclude participation in the study

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to help Black young adults with type 1 diabetes by testing a specialized program called T1DES. The program is designed to address the emotional stress related to diabetes and how it impacts blood

Who is the study for?

This trial is for Black patients aged 18-30 with Type 1 Diabetes, who are Grady Health System patients, have a Hemoglobin A1c > 7.5, and can text on a cell phone. They must be able to read English and consent to the study. It excludes those with cognitive impairments or severe physical disabilities that hinder participation.

What is being tested?

The study tests T1DES, a culturally tailored intervention designed to reduce diabetes distress among young Black adults with Type 1 Diabetes. The goal is to see if it improves their diabetes management compared to standard diabetes education.

What are the potential side effects?

Since this trial focuses on educational interventions rather than medications, there may not be direct side effects like those seen in drug trials; however, participants might experience emotional or psychological responses related to the content of the education sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 30 years old.

Select...

I have been diagnosed with Type 1 diabetes.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have a visual, hearing, or physical disability that makes it hard for me to join group or web sessions.

Select...

I do not have severe diabetes complications.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

A1C

Diabetes Distress

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: T1DESExperimental Treatment1 Intervention

Participants in this arm will receive a emotion regulation intervention called T1DES following a baseline assessment. During months 1-3, participants will attend 5 sessions. Follow-up will be conducted at 3-months and 6-months.

Group II: Diabetes EducationActive Control1 Intervention

Participants in this arm will receive traditional diabetes education following a baseline assessment. During months 1-3, participants will attend 5 sessions. Follow up will be conducted at 3-months and 6-months.

0 / 4Eligibility criteria met